Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Recruiting

Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT03936153

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
  • China-Japan Friendship Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
  • West China Hospital, Sichuan University Chengdu, China
View all 23 locations
View Trial Details
Recruiting

Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure

NCT06918912

Conditions
B-Cell Lymphoma Treatment, Diffuse Large B-cell Lymphoma, Disease Attributes, +16 more
Locations
  • Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo Alessandria, ALESSANDRIA, Italy
  • Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola Bologna, BO, Italy
  • Azienda Sanitaria Ospedaliera Santa Croce e Carle di Cuneo Cuneo, Italy
  • Ospedale San Raffaele Milan, MILANO, Italy
View Trial Details
Recruiting

Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL

NCT06760039

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Fujian Provincial Cancer Hospital Fuzhou, Fujian, China
  • Gansu Provincial Cancer Hospital Lanzhou, Gansu, China
  • The Fifth Affiliated Hospital of Guangzhou Medical University. Guangzhou, Guangdong, China
  • The Affiliated Hospital of Guangdong Medical University Guangzhou, Guangdong, China
View Trial Details
Recruiting

Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma

NCT06854445

Conditions
Diffuse Large Cell B-lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Gansu Provincial Cancer Hospital Lanzhou, Gansu, China
  • Affiliated Cancer Hospital and insititute Guangzhou Medical University Guangzhou, Guangdong, China
View all 24 locations
View Trial Details

Related conditions